These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Observation of long-term therapeutic outcome in chronic granulocytic leukemia]. Liu B; Wang Y; Hao C; Liu Y; Qian L Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):61-3. PubMed ID: 11877049 [TBL] [Abstract][Full Text] [Related]
24. Rotational therapy with a colchicine analog in chronic granulocytic leukemia. Stolinsky DC; Weiner JM; Bateman JR Oncology; 1980; 37(1):62-3. PubMed ID: 6927936 [TBL] [Abstract][Full Text] [Related]
25. Busulphan versus combination chemotherapy for initial treatment of chronic granulocytic leukaemia. Jacobs P Am J Hematol; 1986 Aug; 22(4):375-80. PubMed ID: 3460327 [TBL] [Abstract][Full Text] [Related]
26. Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells. Karp DD; Parker LM; Binder N; Tantravahi R; Smith BR; Ervin TJ; Canellos GP Am J Hematol; 1985 Mar; 18(3):243-9. PubMed ID: 2858155 [TBL] [Abstract][Full Text] [Related]
28. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases]. Nese M; de Bellis R; Urtiarte R; Di Landro J Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047 [TBL] [Abstract][Full Text] [Related]
29. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia. Lockhart S; Plunkett W; Jeha S; Ramirez I; Zipf T; Cork A; Pinkel D J Clin Oncol; 1994 Mar; 12(3):587-95. PubMed ID: 8120558 [TBL] [Abstract][Full Text] [Related]
30. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia. Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198 [TBL] [Abstract][Full Text] [Related]
31. Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemia. Gandhi V; Plunkett W; Kantarjian H; Talpaz M; Robertson LE; O'Brien S J Clin Oncol; 1998 Jul; 16(7):2321-31. PubMed ID: 9667246 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic value of the terminal deoxynucleotidyl transferase (TdT) activity in treating the blastic phase (bp) of chronic granulocytic leukaemia (CGL). Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M; Duraj M; Jarczok K; Hołowiecka B; Suhs M Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):864-71. PubMed ID: 2419215 [TBL] [Abstract][Full Text] [Related]
40. Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases. Fredly H; Stapnes Bjørnsen C; Gjertsen BT; Bruserud Ø Hematology; 2010 Oct; 15(5):338-43. PubMed ID: 20863429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]